We're starting to get a better picture of how artificial intelligence could help doctors better treat cancer. And in data presented at the American Society of Clinical Oncology meeting, IBM Watson Health gave a snapshot of how it's playing out so far. The studies looked at concordance rates, or how often Watson for Oncology reached the same course of treatment as the cancer doctors at different cancer centers around the world. At Manipal Comprehensive Cancer Center in India, for 112 cases of lung cancer, there was 96.4% concordance between Watson and the doctors. For 126 cases of colon cancer it was 81% of the time, and for 124 cases of rectal cancer cases were 92.7%.

Background: IBM Watson for Oncology is an artificial intelligence cognitive computing system that provides confidence-ranked, evidence-based treatment recommendations for cancer. In the present study, we examine the level of agreement for lung and colorectal cancer therapy between the multidisciplinary tumour board from Manipal Comprehensive Cancer Centre in Bangalore, India, and Watson for Oncology. Methods: Watson for Oncology is a Memorial Sloan Kettering Cancer Center (New York, USA) trained cognitive computing system that uses natural language processing and machine learning to provide treatment recommendations. It processes structured and unstructured data from medical literature, treatment guidelines, medical records, imaging, lab and pathology reports, and the expertise of Memorial Sloan Kettering experts to formulate therapeutic recommendations. Treatment recommendations are provided in three categories: recommended, for consideration and not recommended.

Artificial intelligence (AI) is rapidly moving from "nice to have" into "must have" territory for organizations. In fact, nearly six in ten AI early adopters think it will be a necessary element to remain competitive within the next few years. Two-thirds say AI is very important to their organization's strategy and success. AI can be a powerful tool for getting people the right information at the right time for decision making. By augmenting human intelligence and improving planning, AI has the potential to transform workplace productivity.

Jeopardy-winning Watson is getting better and better at designing cancer treatments. New data presented this week at the American Society of Clinical Oncology's annual meeting show that IBM's Watson for Oncology suggests cancer treatments that are often in-line with what physicians recommend. The company also announced that the cancer care product, designed to help physicians diagnose and treat their patients, is being used by nine new medical centers around the world. In a handful of studies being presented at ASCO, researchers show that Watson for Oncology is pretty dang good at recommending treatments for a variety of different cancers. From research done in India, Watson's treatment recommendations were in agreement with those of physicians 96 percent of the time for lung cancer, 93 percent of the time for rectal cancer, and 81 percent of the time for colon cancer.

US research firm International Data Corporation predicts that by 2020, businesses will spend over $100 billion to protect themselves from hacking, up from the estimated $74 billion budget last year. However, new technologies such as artificial intelligence and quantum computing can reportedly help prevent cyberattacks. Artificial intelligence, for instance, could enhance threat detection, shorten defense response time, and improve ways of distinguishing real efforts from those that can be ignored, the Financial Times noted. "Before artificial intelligence, we'd have to assume that a lot of the data - say 90 percent - is fine. We only would have bandwidth to analyze this 10 percent," Daniel Driver from UK defense group's Chemring Technology Solution said. IBM is also developing its own AI security platform called Watson.

Digital business platform provider Magnolia formed a partnership with IBM in 2015 to integrate with its IBM Marketing Cloud. With the integration, Magnolia users could incorporate the email marketing, lead management and mobile engagement solutions the platform provided into their daily workflows. When Armonk, NY-based IBM folded its Marketing Cloud under the broader umbrella of Watson Marketing in March, the capabilities expanded, which meant good news for Magnolia users. By installing the Magnolia Silverpop Module, Magnolia customers with a Watson Marketing account can plug their Magnolia instances into IBM Watson, bringing further capabilities for personalized content delivery based on scoring models derived from visitor behavior. IBM Watson can, "analyze and interpret all of your data, including unstructured text, images, audio and video [with the aim of] providing personalized recommendations by understanding a user's personality, tone and emotion."

IBM Watson Group opened a $200 million Internet of Things (IoT) headquarters today in Munich, Germany, what the company is calling its biggest investment in Europe in more than two decades. There more than 1,000 IBM engineers and designers will work with IBM clients and partners in what IBM Watson general manager Harriet Green called a "collaboratory." Watson works with 6,000 clients worldwide, according to the company. "This is more than a ribbon cutting or a ceremony. This is an industry moment. We think it is a turning point because at IBM we have always believed that there is only one way to fill the potential of this truly transformational technology, and that is together," Green said today at Genius of Things Summit, a gathering of press, the IoT team, and more than 400 business partners.

Key Points: – The market for AI is on an exponential growth curve and is expected to reach $16.06 billion by 2022. Artificial intelligence is rapidly coming of age, poised to transform businesses and industries globally. The market for AI is on an exponential growth curve and is expected to reach $16.06 billion by 2022. With over half of all developer teams projected to embed AI services in their apps by 2018, it's inevitable that consumers will soon be interacting with these new technologies on a regular basis. While the growing popularity of AI is clear, who's actually driving the adoption of these new technologies at organizations?

The Mirai is Toyota's car of the future. It runs on hydrogen fuel cells, gets 312 miles on a full tank and only emits water vapor. So, to target tech and science enthusiasts, the brand is running thousands of ads with messaging crafted based on their interests. The campaign was written by IBM's supercomputer, Watson. After spending two to three months training the AI to piece together coherent sentences and phrases, Saatchi LA began rolling out a campaign last week on Facebook called "Thousands of Ways to Say Yes" that pitches the car through short video clips.

Watson, IBM's supercomputer, is most well known for beating two quizmasters on popular quiz show Jeopardy! in 2011. The impressive artificially intelligent software was developed to advance machine learning capabilities, including natural language processing, reasoning and knowledge retrieval. Watson can access information from an endless list of sources, from literature to databases. As AI continues to attract investment and R&D, it will impact our lives in so many ways. It's not surprising, then, that Watson has rather expanded its repertoire since its Jeopardy!